Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 608435, 12 pages
http://dx.doi.org/10.1155/2015/608435
Research Article

Modern Evaluation of Liquisolid Systems with Varying Amounts of Liquid Phase Prepared Using Two Different Methods

Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1/3, 612 42 Brno, Czech Republic

Received 2 September 2014; Accepted 7 October 2014

Academic Editor: Josef Jampilek

Copyright © 2015 Barbora Vraníková et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. T. Savjani, A. K. Gajjar, and J. K. Savjani, “Drug solubility: importance and enhancement techniques,” ISRN Pharmaceutics, vol. 2012, Article ID 195727, 10 pages, 2012. View at Publisher · View at Google Scholar
  2. S. Hiendrawan, B. Veriansyah, and R. R. Tjandrawinata, “Micronization of fenofibrate by rapid expansion of supercritical solution,” Journal of Industrial and Engineering Chemistry, vol. 20, no. 1, pp. 54–60, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. Nighute and S. B. Bhise, “Enhancement of dissolution rate of rifabutin by preparation of microcrystals using solvent change method,” International Journal of PharmTech Research, vol. 1, no. 2, pp. 142–148, 2009. View at Google Scholar · View at Scopus
  4. M. Burra, R. Jukanti, K. Y. Janga et al., “Enhanced intestinal absorption and bioavailability of raloxifene hydrochloride via lyophilized solid lipid nanoparticles,” Advanced Powder Technology, vol. 24, no. 1, pp. 393–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Qi, J. Qin, N. Ma, X. Chou, and Z. Wu, “Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation,” International Journal of Pharmaceutics, vol. 472, no. 1-2, pp. 40–47, 2014. View at Publisher · View at Google Scholar
  6. K. Kavitha, K. N. S. Lova Raju, N. S. Ganesh, and B. Ramesh, “Effect of dissolution rate by liquisolid compact approach: an overview,” Der Pharmacia Lettre, vol. 3, no. 1, pp. 71–83, 2011. View at Google Scholar · View at Scopus
  7. V. K. Nagabandi, T. Ramarao, and K. N. Jayaveera, “Liquisolid compacts: a novel approach to enhance bioavailability of poorly soluble drugs,” International Journal of Pharma and Bio Sciences, vol. 1, pp. 89–102, 2011. View at Google Scholar
  8. S. R. Gubbi and R. Jarag, “Formulation and characterization of atorvastatin calcium liquisolid compacts,” Asian Journal of Pharmaceutical Sciences, vol. 5, no. 2, pp. 50–60, 2010. View at Google Scholar · View at Scopus
  9. Y. Javadzadeh, B. Jafari-Navimipour, and A. Nokhodchi, “Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine),” International Journal of Pharmaceutics, vol. 341, no. 1-2, pp. 26–34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Akinlade, A. A. Elkordy, E. A. Essa, and S. Elhagar, “Liquisolid systems to improve the dissolution of Furosemide,” Scientia Pharmaceutica, vol. 78, no. 2, pp. 325–344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Saeedi, J. Akbari, K. Morteza-Semnani, R. Enayati-Fard, S. Sar-Reshteh-dar, and A. Soleymani, “Enhancement of dissolution rate of indomethacin using liquisolid compacts,” Iranian Journal of Pharmaceutical Research, vol. 10, no. 1, pp. 25–34, 2011. View at Google Scholar · View at Scopus
  12. A. Nokhodchi, C. M. Hentzschel, and C. S. Leopold, “Drug release from liquisolid systems: speed it up, slow it down,” Expert Opinion on Drug Delivery, vol. 8, no. 2, pp. 191–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. H. Fahmy and M. A. Kassem, “Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 69, no. 3, pp. 993–1003, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Gavali, S. S. Pacharane, S. V. Sankpal, K. R. Jadhav, and V. J. Kadam, “Liquisolid compact: a new technique for enhancement of drug dissolution,” International Journal of Research in Pharmacy and Chemistry, vol. 1, pp. 2231–2781, 2011. View at Google Scholar
  15. V. B. Yadav and A. V. Yadav, “Improvement of solubility and dissolution of indomethacin by liquisolid and compaction granulation technique,” Journal of Pharmaceutical Sciences and Research, vol. 1, no. 3, pp. 44–51, 2009. View at Google Scholar · View at Scopus
  16. A. B. Karmarkar, I. D. Gonjari, and A. H. Hosmani, “Liquisolid technology for dissolution rate enhancement or sustained release,” Expert Opinion on Drug Delivery, vol. 7, no. 10, pp. 1227–1234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Tiong and A. A. Elkordy, “Effects of liquisolid formulations on dissolution of naproxen,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 73, no. 3, pp. 373–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kaur, R. Bala, and S. Arora, “Formulation and evaluation of liquisolid compacts of amlodipine besylate,” International Research Journal of Pharma, vol. 4, pp. 156–160, 2013. View at Google Scholar
  19. P. H. Jones, M. H. Davidson, A. C. Goldberg et al., “Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: pooled analysis of three phase 3, 12-week randomized, controlled studies,” Journal of Clinical Lipidology, vol. 3, no. 2, pp. 125–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. P. Toth, V. Zarotsky, J. M. Sullivan, and D. Laitinen, “Lipid therapy utilization rates in a managed-care mixed dyslipidemia population,” Journal of Clinical Lipidology, vol. 2, no. 5, pp. 365–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Anfossi, P. Massucco, K. Bonomo, and M. Trovati, “Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 14, no. 4, pp. 215–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. F. McTaggart, “Comparative pharmacology of rosuvastatin,” Atherosclerosis Supplements, vol. 4, no. 1, pp. 9–14, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. Chapman and F. McTaggart, “Optimizing the pharmacology of statins: characteristics of rosuvastatin,” Atherosclerosis Supplements, vol. 2, no. 4, pp. 33–37, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. P. D. Martin, M. J. Warwick, A. L. Dane et al., “Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers,” Clinical Therapeutics, vol. 25, no. 11, pp. 2822–2835, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Spireas and S. M. Bolton, “Liquisolid systems and methods of preparing same,” US6423339; 2002.
  26. S. Spireas and S. M. Bolton, “Liquisolid systems and methods of preparing same,” Tech. Rep. US8096337, 2000. View at Google Scholar
  27. B. Vraníková, J. Gajdziok, and D. Vetchý, “Determination of flowable liquid retention potential of aluminometasilicate carrier for liquisolid systems preparation,” Pharmaceutical Development and Technology, 2014. View at Publisher · View at Google Scholar
  28. “The European Directorate for the Quality of Medicines & HealthCare: European Pharmacopoeia 8.2,” 2014, http://online6.edqm.eu/ep802.
  29. A. B. Karmarkar, I. D. Gonjari, A. H. Hosmani, P. N. Dhabale, and S. B. Bhise, “Liquisolid tablets: a novel approach for drug delivery,” International Journal of Health Research, vol. 2, no. 1, pp. 45–50, 2009. View at Publisher · View at Google Scholar
  30. S. S. Spireas, C. I. Jarowski, and B. D. Rohera, “Powdered solution technology: principles and mechanism,” Pharmaceutical Research, vol. 9, no. 10, pp. 1351–1358, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. S. G. Gumaste, S. A. Pawlak, D. M. Dalrymple, C. J. Nider, L. D. Trombetta, and A. T. M. Serajuddin, “Development of solid SEDDS, IV: effect of adsorbed lipid and surfactant on tableting properties and surface structures of different silicates,” Pharmaceutical Research, vol. 30, no. 12, pp. 3170–3185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. C. M. Hentzschel, A. Sakmann, and C. S. Leopold, “Suitability of various excipients as carrier and coating materials for liquisolid compacts,” Drug Development and Industrial Pharmacy, vol. 37, no. 10, pp. 1200–1207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. “DMV Excipient Guide. [Internet],” 2014, http://www.phexcom.cn/UploadFiles/20130217102234_5017.pdf.
  34. S. Poutiainen, S. Matero, T. Hämäläinen, J. Leskinen, J. Ketolainen, and K. Järvinen, “Predicting granule size distribution of a fluidized bed spray granulation process by regime based PLS modeling of acoustic emission data,” Powder Technology, vol. 228, pp. 149–157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. C. M. Hentzschel, M. Alnaief, I. Smirnova, A. Sakmann, and C. S. Leopold, “Enhancement of griseofulvin release from liquisolid compacts,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 80, no. 1, pp. 130–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. S. T. Prajapati, H. H. Bulchandani, D. M. Patel, S. K. Dumaniya, and C. N. Patel, “Formulation and evaluation of liquisolid compacts for olmesartan medoxomil,” Journal of Drug Delivery, vol. 2013, Article ID 870579, 9 pages, 2013. View at Publisher · View at Google Scholar
  37. P. Komárek and M. Rabišková, Technologie léků Třetí, přepracované a doplněné vydání, Galén, Praha, Czech Republic, 2006.
  38. S. G. Gumaste, D. M. Dalrymple, and A. T. M. Serajuddin, “Development of solid SEDDS, V: compaction and drug release properties of tablets prepared by adsorbing lipid-based formulations onto neusilin US2,” Pharmaceutical Research, vol. 30, no. 12, pp. 3186–3199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. A. A. Elkordy, X. N. Tan, and E. A. Essa, “Spironolactone release from liquisolid formulations prepared with Capryol 90, Solutol HS-15 and Kollicoat SR 30 D as non-volatile liquid vehicles,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 83, no. 2, pp. 203–223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Gubbi and R. Jarag, “Liquisolid technique for enhancement of dissolution properties of bromhexine hydrochloride,” Research Journal of Pharmacy and Technology, vol. 2, no. 2, pp. 382–386, 2009. View at Google Scholar
  41. V. J. Kapure, V. V. Pande, and P. K. Deshmukh, “Dissolution enhancement of rosuvastatin calcium by liquisolid compact technique,” Journal of Pharmaceutics, vol. 2013, Article ID 315902, 9 pages, 2013. View at Publisher · View at Google Scholar
  42. N. Saigal, S. Baboota, A. Ahuja, and J. Ali, “Microcrystalline cellulose as a versatile excipient in drug research,” Journal of Young Pharmacists, vol. 1, pp. 6–12, 2009. View at Publisher · View at Google Scholar
  43. K. Sanka, S. Poienti, A. B. Mohd, and P. V. Diwan, “Improved oral delivery of clonazepam through liquisolid powder compact formulations: in-vitro and ex-vivo characterization,” Powder Technology, vol. 256, pp. 336–344, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. F. J. Sayyad, S. L. Tulsankar, and U. B. Kolap, “Design and development of liquisolid compact of candesartan cilexetil to enhance dissolution,” Journal of Pharmacy Research, vol. 7, no. 5, pp. 381–388, 2013. View at Publisher · View at Google Scholar